LAKEPHARMA, INC. – Trademark Portfolio

Entity Type: 03

LAKEPHARMA, INC. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 31 (Natural Agricultural Products) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PENTAMICE. The owner is based in Irving, TX.

4343 W. Royal Lane, Suite 126

Irving, TX 75063

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PENTAMICE
PENTAMICE
Registered 2019

Trademark Classifications

LAKEPHARMA, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

31
Natural Agricultural Products (1 filing)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

Frequently Asked Questions

How many trademarks does LAKEPHARMA, INC. have?

LAKEPHARMA, INC. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does LAKEPHARMA, INC. file in?

LAKEPHARMA, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 31 (Natural Agricultural Products). Class 42 covers scientific and technological services; industrial analysis and research services.

What are LAKEPHARMA, INC.'s most well-known trademarks?

LAKEPHARMA, INC.'s registered trademark portfolio includes well-known marks such as PENTAMICE. These are among 1 currently registered trademark in the portfolio.

What is LAKEPHARMA, INC.'s trademark registration success rate?

LAKEPHARMA, INC. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.